THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA) noted today that its financial statements for the fiscal year ended December 31, 2006, included in Amendment No. 1 to the Company’s Report on Form 10-KSB/A filed on November 9, 2007, contains a going concern modification from its independent accounting firm, Malone & Bailey, PC.
